New FDA Guidance Documents in Calendar Year 2011
Register now for ECA's GMP Newsletter
On January 26, 2011 the FDA issued the Guidance Agenda: New & Revised Draft Guidances CDER plans on publishing during the calendar year 2011.
The document is structured in different categories. With regard to Current Good Manufacturing Practices (CGMPs)/Compliance a number of documents are listed. Some of them will be of high interest for industry, like:
- Contract Manufacturing
- Control of Highly Potent Compounds
- Importation of Active Pharmaceutical Ingredients (API) for Use in Human Drugs
- Non-Penicillin Beta-Lactam Contamination
- Pharmaceutical Component Quality Control
- Compliance Policy Guide Section 490.200 for FDA Staff: Parametric Release - Drug Products Terminally Sterilized by Moist Heat
In the category "Chemistry" the FDA plans on developing among others the following Guidelines:
- CMC Postapproval Changes Reportable in an Annual Report and
- Comparability Protocols for Approved Drugs: CMC Information
Source: Federal Register and CDER Webpage
Related GMP News
17.09.2025When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025
17.09.2025Dealing with Systems without Audit Trail Functionality
17.09.2025Why is RCA (Root Cause Analysis) so important?
10.09.2025The Use of Hoses in Pharmaceutical Production
10.09.2025Revision of EU-GMP Chapter 1 planned with Consultation Phase
10.09.2025Audit Trail Review by the QP / Dealing with a Lack of Justification